Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase II Trial of SIRT vs TACE in Liver Metastases from Uveal Melanoma
2014-002439-32Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cisplatin in intraocular melanoma (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Progression-free survival. Started Feb 2015; status: completed.
02
Drugs
cisplatin
03
Conditions
intraocular melanoma
Beyond the preview
Go deeper on 2014-002439-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002439-32.